217 related articles for article (PubMed ID: 38717950)
1. CRISPR-Cas Genome Editing in
Mesaki K; Yamamoto H; Juvet S; Yeung J; Guan Z; Akhter A; Yao Y; Dickie C; Mangat H; Wang A; Wilson GW; Mariscal A; Hu J; Davidson AR; Kleinstiver BP; Cypel M; Liu M; Keshavjee S
Hum Gene Ther; 2024 Jun; 35(11-12):374-387. PubMed ID: 38717950
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation of the donor lung with CRISPR-mediated activation of IL-10 expression.
Mesaki K; Juvet S; Yeung J; Guan Z; Wilson GW; Hu J; Davidson AR; Kleinstiver BP; Cypel M; Liu M; Keshavjee S
J Heart Lung Transplant; 2023 Oct; 42(10):1363-1377. PubMed ID: 37315746
[TBL] [Abstract][Full Text] [Related]
3. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
Wilbie D; Walther J; Mastrobattista E
Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
[TBL] [Abstract][Full Text] [Related]
4. Gene editing and CRISPR in the clinic: current and future perspectives.
Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
[TBL] [Abstract][Full Text] [Related]
5. Engineering the Delivery System for CRISPR-Based Genome Editing.
Glass Z; Lee M; Li Y; Xu Q
Trends Biotechnol; 2018 Feb; 36(2):173-185. PubMed ID: 29305085
[TBL] [Abstract][Full Text] [Related]
6. In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications.
Huang K; Zapata D; Tang Y; Teng Y; Li Y
Biomaterials; 2022 Dec; 291():121876. PubMed ID: 36334354
[TBL] [Abstract][Full Text] [Related]
7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
8. Viral Delivery of Compact CRISPR-Cas12f for Gene Editing Applications.
Sharrar A; Meacham Z; Staples-Ager J; Arake de Tacca L; Rabuka D; Collingwood T; Schelle M
CRISPR J; 2024 Jun; 7(3):150-155. PubMed ID: 38695159
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the CRISPR-Based Therapeutics.
Li B; Niu Y; Ji W; Dong Y
Trends Pharmacol Sci; 2020 Jan; 41(1):55-65. PubMed ID: 31862124
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
Dong W; Kantor B
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
[TBL] [Abstract][Full Text] [Related]
11. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors.
Boucher P; Cui X; Curiel DT
J Control Release; 2020 Nov; 327():788-800. PubMed ID: 32891680
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications.
Li Y; Glass Z; Huang M; Chen ZY; Xu Q
Biomaterials; 2020 Mar; 234():119711. PubMed ID: 31945616
[TBL] [Abstract][Full Text] [Related]
14. Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors.
Shalaby K; Aouida M; El-Agnaf O
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027946
[TBL] [Abstract][Full Text] [Related]
15. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
Bae T; Hur JW; Kim D; Hur JK
Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor Vector Made by Gibson Assembly.
Sahoo N; Cuello V; Udawant S; Litif C; Mustard JA; Keniry M
Methods Mol Biol; 2020; 2115():365-383. PubMed ID: 32006411
[TBL] [Abstract][Full Text] [Related]
17. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for
Wei T; Cheng Q; Farbiak L; Anderson DG; Langer R; Siegwart DJ
ACS Nano; 2020 Aug; 14(8):9243-9262. PubMed ID: 32697075
[TBL] [Abstract][Full Text] [Related]
18. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in CRISPR technologies for genome editing.
Song M; Koo T
Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
[TBL] [Abstract][Full Text] [Related]
20. Agrobacterium-mediated delivery of CRISPR/Cas reagents for genome editing in plants enters an era of ternary vector systems.
Zhang Y; Zhang Q; Chen QJ
Sci China Life Sci; 2020 Oct; 63(10):1491-1498. PubMed ID: 32279281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
